NASDAQ : CCCC
C4 Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 405.98M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
C4 Therapeutics, Inc. (CCCC) reported revenue of 35.04M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 35.04M | 35.95M | 35.58M | 20.76M | 31.10M | 45.78M |
| Cost of Revenue | 4.79M | 8.98M | 12.54M | 117.71M | 117.84M | 94.67M |
| Gross Profit | 30.25M | 26.97M | 23.05M | -96.95M | -86.75M | -48.88M |
| Selling, General & Admin | 36.02M | 36.20M | 42.12M | 42.08M | 42.79M | 33.25M |
| Research & Development | 95.26M | 95.26M | 98.10M | |||
| Operating Expenses | 131.29M | 131.46M | 140.22M | 42.08M | 42.79M | 33.25M |
| Operating Income | -101.03M | -104.49M | -117.18M | -139.03M | -129.53M | -82.13M |
| Interest Expense | -1.37M | -2.22M | -2.15M | |||
| Interest & Investment Income | 7.82M | 7.61M | 9.03M | 6.03M | 4.29M | 2.27M |
| EBT Excluding Unusual Items | -93.22M | -96.88M | -108.14M | -134.38M | -127.46M | -82.01M |
| Merger & Restructuring Charges | -2.44M | |||||
| Gain (Loss) on Sale of Investments | 2.65M | 2.74M | 5.40M | 3.78M | -714.00K | -1.88M |
| Asset Writedown | -10.73M | -10.73M | ||||
| Other Unusual Items | -621.00K | |||||
| Pretax Income | -101.30M | -104.87M | -105.19M | -131.21M | -128.18M | -83.89M |
| Income Tax Expense | 121.00K | 121.00K | 131.00K | 1.28M | ||
| Net Income | -101.42M | -104.99M | -105.32M | -132.49M | -128.18M | -83.89M |
| Net Income to Common | -101.42M | -104.99M | -105.32M | -132.49M | -128.18M | -83.89M |
| Shares Outstanding (Basic) | 111.63M | 82.89M | 69.37M | 49.64M | 48.86M | 46.04M |
| Shares Outstanding (Diluted) | 111.63M | 82.89M | 69.37M | 49.64M | 48.86M | 46.04M |
| EPS (Basic) | -0.91 | -1.27 | -1.52 | -2.67 | -2.62 | -1.82 |
| EPS (Diluted) | -0.91 | -1.27 | -1.52 | -2.67 | -2.62 | -1.82 |
| Free Cash Flow | -85.39M | -99.30M | -65.34M | -108.55M | -111.44M | -88.24M |
| Free Cash Flow Per Share | -0.77 | -1.20 | -0.94 | -2.19 | -2.28 | -1.92 |
| Gross Margin | 86.34% | 75.03% | 64.76% | -278.96% | -106.76% | |
| Operating Margin | -288.34% | -290.68% | -329.30% | -669.83% | -416.56% | -179.39% |
| Profit Margin | -289.44% | -292.08% | -295.96% | -638.34% | -412.19% | -183.23% |
| Free Cash Flow Margin | -243.71% | -276.24% | -183.61% | -522.96% | -358.36% | -192.73% |
| EBITDA | -99.45M | -102.53M | -115.36M | -137.15M | -127.86M | -80.64M |
| EBITDA Margin | -283.82% | -285.23% | -176.13% | |||
| D&A For EBITDA | 1.58M | 1.96M | 1.82M | 1.88M | 1.68M | 1.49M |
| EBIT | -101.03M | -104.49M | -117.18M | -139.03M | -129.53M | -82.13M |
| EBIT Margin | -288.34% | -290.68% | -179.39% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 78.61M | 74.60M | 55.50M | 126.59M | 29.75M | 76.12M |
| Short-Term Investments | 175.05M | 173.93M | 189.41M | 127.09M | 246.40M | 233.16M |
| Cash & Short-Term Investments | 253.66M | 248.54M | 244.90M | 253.68M | 276.15M | 309.28M |
| Receivables | 1.33M | 2.40M | 3.10M | 11.80M | 1.47M | 5.72M |
| Prepaid Expenses | 7.91M | 7.17M | 9.76M | 5.71M | 9.93M | 10.69M |
| Total Current Assets | 262.90M | 258.11M | 257.77M | 271.19M | 287.56M | 325.69M |
| Property, Plant & Equipment | 41.79M | 45.28M | 63.38M | 71.09M | 77.52M | 35.05M |
| Long-Term Investments | 46.79M | 48.56M | 22.36M | 28.01M | 60.96M | 142.20M |
| Other Long-Term Assets | 7.93M | 7.13M | 6.10M | 6.17M | 4.80M | 3.82M |
| Total Assets | 359.40M | 359.07M | 349.60M | 376.45M | 430.84M | 506.76M |
| Accounts Payable | 1.12M | 858.00K | 1.33M | 1.45M | 1.17M | 4.51M |
| Accrued Expenses | 12.79M | 11.91M | 17.49M | 15.49M | 16.66M | 13.19M |
| Current Portion of Long-Term Debt | 2.29M | |||||
| Current Portion of Leases | 6.68M | 6.37M | 5.77M | 5.22M | 4.70M | 1.33M |
| Current Unearned Revenue | 26.66M | 12.49M | 18.71M | 15.47M | 16.62M | 31.80M |
| Other Current Liabilities | 995.00K | 1.40M | 1.87M | 5.14M | 3.11M | 413.00K |
| Total Current Liabilities | 48.25M | 33.03M | 45.18M | 42.77M | 44.55M | 51.25M |
| Long-Term Debt | 9.20M | 10.77M | ||||
| Long-Term Leases | 50.18M | 53.62M | 59.98M | 65.76M | 70.97M | 30.78M |
| Long-Term Unearned Revenue | 13.71M | 15.84M | 28.46M | 21.81M | 16.89M | 24.37M |
| Total Liabilities | 112.14M | 102.49M | 133.62M | 130.34M | 141.61M | 117.16M |
| Common Stock | 12.00K | 9.00K | 7.00K | 6.00K | 5.00K | 5.00K |
| Additional Paid-In Capital | 1.04B | 995.22M | 849.62M | 774.62M | 689.26M | 658.09M |
| Retained Earnings | -787.46M | -738.69M | -633.70M | -528.38M | -395.89M | -267.71M |
| Comprehensive Income & Other | -444.00K | 50.00K | 53.00K | -127.00K | -4.14M | -775.00K |
| Total Common Equity | 247.26M | 256.59M | 215.99M | 246.11M | 289.23M | 389.61M |
| Shareholders' Equity | 247.26M | 256.59M | 215.99M | 246.11M | 289.23M | 389.61M |
| Total Liabilities & Equity | 359.40M | 359.07M | 349.60M | 376.45M | 430.84M | 506.76M |
| Total Debt | 56.86M | 59.98M | 65.76M | 70.98M | 87.15M | 42.88M |
| Net Cash (Debt) | 243.59M | 237.12M | 201.51M | 210.71M | 249.96M | 408.60M |
| Net Cash Per Share | 2.18 | 2.86 | 2.90 | 4.24 | 5.12 | 8.87 |
| Filing Date Shares Outstanding | 123.03M | 97.58M | 70.99M | 68.60M | 49.05M | 48.74M |
| Total Common Shares Outstanding | 122.91M | 96.91M | 70.63M | 60.47M | 48.97M | 48.69M |
| Working Capital | 214.66M | 225.08M | 212.59M | 228.42M | 243.01M | 274.44M |
| Book Value Per Share | 2.01 | 2.65 | 3.06 | 4.07 | 5.91 | 8.00 |
| Tangible Book Value | 247.26M | 256.59M | 215.99M | 246.11M | 289.23M | 389.61M |
| Tangible Book Value Per Share | 2.01 | 2.65 | 3.06 | 4.07 | 5.91 | 8.00 |
| Machinery | 11.07M | 10.97M | 10.37M | 10.18M | 10.66M | 9.48M |
| Construction In Progress | 183.00K | |||||
| Leasehold Improvements | 4.55M | 4.55M | 4.71M | 4.71M | 4.68M | 541.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -101.42M | -104.99M | -105.32M | -132.49M | -128.18M | -83.89M |
| Depreciation & Amortization | 1.58M | 1.96M | 1.82M | 1.88M | 1.68M | 1.49M |
| Other Amortization | 405.00K | 713.00K | 719.00K | |||
| Asset Writedown & Restructuring Costs | 10.73M | 10.73M | 6.16M | |||
| Loss (Gain) From Sale of Investments | -2.65M | -2.74M | -5.40M | -3.78M | 714.00K | 1.88M |
| Stock-Based Compensation | 14.31M | 19.10M | 29.66M | 27.23M | 30.02M | 21.51M |
| Other Operating Activities | 6.11M | 6.53M | 6.43M | 698.00K | 5.90M | 1.42M |
| Change in Accounts Receivable | 867.00K | 701.00K | 8.70M | -10.33M | 4.24M | -1.23M |
| Change in Accounts Payable | -1.09M | -468.00K | -119.00K | 273.00K | -3.33M | -1.18M |
| Change in Unearned Revenue | -3.40M | -18.84M | 9.88M | 3.77M | -22.65M | -25.05M |
| Change in Other Net Operating Assets | -9.91M | -10.68M | -10.81M | -656.00K | 4.96M | -2.63M |
| Operating Cash Flow | -84.87M | -98.69M | -65.16M | -106.84M | -105.94M | -86.97M |
| Capital Expenditures | -523.00K | -607.00K | -180.00K | -1.71M | -5.50M | -1.28M |
| Investment in Securities | -74.79M | -7.99M | -51.09M | 160.06M | 63.92M | -188.06M |
| Investing Cash Flow | -75.31M | -8.60M | -51.27M | 158.35M | 58.42M | -189.34M |
| Long-Term Debt Repaid | -12.50M | |||||
| Net Debt Issued (Repaid) | -12.50M | |||||
| Issuance of Common Stock | 160.65M | 126.32M | 45.15M | 57.73M | 777.00K | 183.09M |
| Repurchase of Common Stock | -238.00K | -193.00K | -194.00K | -110.00K | ||
| Other Financing Activities | 221.00K | 274.00K | 382.00K | 368.00K | 370.00K | -11.70M |
| Financing Cash Flow | 160.63M | 126.40M | 45.34M | 45.49M | 1.15M | 171.40M |
| Net Cash Flow | 453.00K | 19.10M | -71.09M | 97.00M | -46.37M | -104.90M |
| Free Cash Flow | -85.39M | -99.30M | -65.34M | -108.55M | -111.44M | -88.24M |
| Free Cash Flow Margin | -243.71% | -276.24% | -183.61% | -522.96% | -358.36% | -192.73% |
| Free Cash Flow Per Share | -0.77 | -1.20 | -0.94 | -2.19 | -2.28 | -1.92 |
| Levered Free Cash Flow | -43.66M | -54.30M | -35.43M | -66.06M | -62.78M | -30.22M |
| Unlevered Free Cash Flow | -43.66M | -54.30M | -35.43M | -65.60M | -62.11M | -29.59M |
| Cash Interest Paid | 990.00K | 1.62M | 1.31M | |||
| Cash Income Tax Paid | 1.00M | |||||
| Change in Working Capital | -13.53M | -29.28M | 7.65M | -6.94M | -16.78M | -30.09M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 404.14M | 185.11M | 254.12M | 278.44M | 288.85M | 1.57B |
| Enterprise Value | 160.55M | 46.81M | 36.82M | 104.19M | 10.89M | 1.11B |
| Last Close Price | 3.37 | 1.91 | 3.60 | 5.65 | 5.90 | 32.20 |
| PS Ratio | 11.48 | 5.15 | 7.14 | 13.41 | 9.29 | 34.20 |
| PB Ratio | 1.68 | 0.72 | 1.18 | 1.13 | 1.00 | 4.02 |
| P/TBV Ratio | 1.63 | 0.72 | 1.18 | 1.13 | 1.00 | 4.02 |
| EV/Sales Ratio | 4.53 | 1.30 | 1.03 | 5.02 | 0.35 | 24.20 |
| Debt / Equity Ratio | 0.23 | 0.23 | 0.30 | 0.29 | 0.30 | 0.11 |
| Net Debt / Equity Ratio | -0.98 | -0.92 | -0.93 | -0.86 | -0.86 | -1.05 |
| Net Debt / EBITDA Ratio | 2.45 | 2.31 | 1.75 | 1.54 | 1.96 | 5.07 |
| Net Debt / FCF Ratio | 2.85 | 2.39 | 3.08 | 1.94 | 2.24 | 4.63 |
| Asset Turnover | 0.11 | 0.10 | 0.10 | 0.05 | 0.07 | 0.10 |
| Quick Ratio | 5.29 | 7.60 | 5.49 | 6.21 | 6.23 | 6.15 |
| Current Ratio | 5.45 | 7.81 | 5.71 | 6.34 | 6.46 | 6.36 |
| Return on Equity (ROE) | -48.14% | -44.44% | -45.58% | -49.50% | -37.76% | -25.03% |
| Return on Assets (ROA) | -19.25% | -18.43% | -20.17% | -21.53% | -17.27% | -11.32% |
| Return on Capital Employed (ROCE) | -32.50% | -32.00% | -38.50% | -41.70% | -33.50% | -18.00% |
| Earnings Yield | -27.66% | -56.72% | -41.44% | -47.58% | -44.38% | -5.36% |
| FCF Yield | -21.23% | -53.64% | -25.71% | -38.98% | -38.58% | -5.64% |
| Buyback Yield / Dilution | -58.30% | -19.49% | -39.75% | -1.59% | -6.12% | -304.93% |